{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:48:57Z","timestamp":1791564537402,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021954","name":"Tour de Cure","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022712","name":"Mark Hughes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022712","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["MethodsX"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.mex.2026.103984","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:55:28Z","timestamp":1780415728000},"page":"103984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exploring the role of advanced MRI in understanding glioblastoma biology: A scoping review protocol"],"prefix":"10.1016","volume":"16","author":[{"given":"James","family":"Brown-Miles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oun","family":"Al-iedani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Hondermarck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadallah","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mex.2026.103984_bib0001","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/jmri.28662","article-title":"Advanced MR Techniques for preoperative Glioma characterization: part 1","volume":"57","author":"Hirschler","year":"2023","journal-title":"J. Magn. Reson. Imaging"},{"issue":"3","key":"10.1016\/j.mex.2026.103984_bib0002","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3348\/kjr.2024.0982","article-title":"A radiologist's guide to IDH-wildtype glioblastoma for efficient communication with clinicians: part I-essential information on preoperative and immediate postoperative imaging","volume":"26","author":"Vollmuth","year":"2025","journal-title":"Korean J. Radiol."},{"key":"10.1016\/j.mex.2026.103984_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2016.12.008","article-title":"The utility of diffusion MRI with quantitative ADC measurements for differentiating high-grade from low-grade cerebral gliomas: evidence from a meta-analysis","volume":"373","author":"Zhang","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.mex.2026.103984_bib0004","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/brain\/awac360","article-title":"Structural connectome quantifies tumour invasion and predicts survival in glioblastoma patients","volume":"146","author":"Wei","year":"2023","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.mex.2026.103984_bib0005","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/jmri.28663","article-title":"Advanced MR techniques for preoperative glioma characterization: part 2","volume":"57","author":"Hangel","year":"2023","journal-title":"J. Magn. Reson. Imaging"},{"issue":"4","key":"10.1016\/j.mex.2026.103984_bib0006","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1148\/rg.210054","article-title":"Quantitative susceptibility mapping: basic methods and clinical applications","volume":"42","author":"Harada","year":"2022","journal-title":"Radiographics."},{"issue":"7","key":"10.1016\/j.mex.2026.103984_bib0007","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/neuonc\/noae049","article-title":"Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: a report of the PET\/RANO group","volume":"26","author":"Galldiks","year":"2024","journal-title":"Neuro Oncol."},{"issue":"9","key":"10.1016\/j.mex.2026.103984_bib0008","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/neuonc\/noaa141","article-title":"Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas","volume":"22","author":"Boxerman","year":"2020","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.mex.2026.103984_bib0009","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/mrm.29241","article-title":"Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: application to brain tumors","volume":"88","author":"Zhou","year":"2022","journal-title":"Magn. Reson. Med."},{"issue":"5","key":"10.1016\/j.mex.2026.103984_bib0010","doi-asserted-by":"crossref","first-page":"e4484","DOI":"10.1002\/nbm.4484","article-title":"Minimum reporting Standards for in vivo Magnetic resonance spectroscopy (MRSinMRS): experts' consensus recommendations","volume":"34","author":"Lin","year":"2021","journal-title":"NMR Biomed."},{"issue":"1","key":"10.1016\/j.mex.2026.103984_bib0011","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jmri.28869","article-title":"Efficiency and accuracy evaluation of multiple diffusion-weighted MRI techniques across different scanners","volume":"59","author":"Crop","year":"2024","journal-title":"J. Magn. Reson. Imaging"},{"issue":"3","key":"10.1016\/j.mex.2026.103984_bib0012","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jmri.28743","article-title":"The 2021 WHO classification for Gliomas and implications on imaging diagnosis: part 1-key points of the fifth edition and summary of imaging findings on adult-type diffuse gliomas","volume":"58","author":"Park","year":"2023","journal-title":"J. Magn. Reson. Imaging"},{"issue":"8","key":"10.1016\/j.mex.2026.103984_bib0013","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/neuonc\/noab120","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications","volume":"23","author":"Wen","year":"2021","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.mex.2026.103984_bib0014","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cncr.33918","article-title":"Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system","volume":"128","author":"Gritsch","year":"2022","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.mex.2026.103984_bib0015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41374-021-00667-6","article-title":"Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System","volume":"102","author":"Komori","year":"2022","journal-title":"Lab. Invest."},{"issue":"2","key":"10.1016\/j.mex.2026.103984_bib0016","article-title":"Reclassification of Glioblastoma multiforme according to the 2021 World Health Organization Classification of Central nervous system Tumors: a single institution report and practical significance","volume":"14","author":"Stoyanov","year":"2022","journal-title":"Cureus."},{"key":"10.1016\/j.mex.2026.103984_bib0017","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1748-717X-6-115","article-title":"Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward, and one step back?","volume":"6","author":"Combs","year":"2011","journal-title":"Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.mex.2026.103984_bib0018","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/neuonc\/noy132","article-title":"MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges","volume":"21","author":"Mansouri","year":"2019","journal-title":"Neuro Oncol."},{"issue":"5","key":"10.1016\/j.mex.2026.103984_bib0019","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.mex.2026.103984_bib0020","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jocn.2008.12.005","article-title":"The EGFRvIII variant in glioblastoma multiforme","volume":"16","author":"Gan","year":"2009","journal-title":"J. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.mex.2026.103984_bib0021","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/biomedicines10030728","article-title":"Detection of TERT promoter mutations as a prognostic biomarker in gliomas: methodology, prospects, and advances","volume":"10","author":"Hasanau","year":"2022","journal-title":"Biomedicines."},{"issue":"2","key":"10.1016\/j.mex.2026.103984_bib0022","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s00330-019-06379-2","article-title":"Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas","volume":"30","author":"Yoo","year":"2020","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.mex.2026.103984_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2024.111477","article-title":"Structural changes in corticospinal tract profiling via multishell diffusion models and their relation to overall survival in glioblastoma","volume":"175","author":"Wang","year":"2024","journal-title":"Eur. J. Radiol."},{"issue":"2","key":"10.1016\/j.mex.2026.103984_bib0024","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/neuonc\/noy169","article-title":"Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival","volume":"21","author":"John","year":"2019","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.mex.2026.103984_bib0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00062-014-0289-3","article-title":"Pretreatment dynamic susceptibility contrast MRI perfusion in glioblastoma: prediction of EGFR gene amplification","volume":"25","author":"Gupta","year":"2015","journal-title":"Clin. Neuroradiol."},{"issue":"1","key":"10.1016\/j.mex.2026.103984_bib0026","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10334-021-00989-y","article-title":"Diagnostic performance of edited 2HG MR spectroscopy of central glioma in the clinical environment","volume":"35","author":"Juskanic","year":"2022","journal-title":"MAGMa"},{"issue":"4","key":"10.1016\/j.mex.2026.103984_bib0027","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nm.2682","article-title":"2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas","volume":"18","author":"Choi","year":"2012","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.mex.2026.103984_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42464","article-title":"Systematic review of functional magnetic resonance imaging (fMRI) applications in the preoperative planning and treatment assessment of brain tumors","volume":"11","author":"Abu Mhanna","year":"2025","journal-title":"Heliyon."},{"key":"10.1016\/j.mex.2026.103984_bib0029","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mri.2024.06.004","article-title":"Beyond conventional imaging: advancements in MRI for glioma malignancy prediction and molecular profiling","volume":"112","author":"\u015aledzi\u0144ska-Bebyn","year":"2024","journal-title":"Magn. Reson. ImAging"},{"key":"10.1016\/j.mex.2026.103984_bib0030","article-title":"Differentiation between high-grade glioma and brain metastasis using cerebral perfusion-related parameters (Cerebral Blood Volume and Cerebral Blood Flow): a systematic review and meta-analysis of perfusion-weighted MRI techniques","author":"Mohammadi","year":"2024","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.mex.2026.103984_bib0031","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.wneu.2024.07.037","article-title":"Diffusion tensor imaging (DTI) biomarker alterations in brain metastases and comparable tumors: a systematic review of DTI and tractography findings","volume":"190","author":"Ghaderi","year":"2024","journal-title":"World Neurosurg."},{"issue":"Pt 2","key":"10.1016\/j.mex.2026.103984_bib0032","article-title":"A systematic review on deep learning based brain tumor segmentation and detection using MRI: past insights, present techniques and future trends","volume":"120","author":"Pasunoori","year":"2026","journal-title":"Comput. Biol. Chem."},{"issue":"9","key":"10.1016\/j.mex.2026.103984_bib0033","first-page":"25","article-title":"Advanced deep learning and machine learning techniques for MRI brain tumor analysis: a review","author":"Missaoui","year":"2025","journal-title":"Sensors. (Basel)"},{"issue":"8","key":"10.1016\/j.mex.2026.103984_bib0034","article-title":"Advanced MRI, radiomics and radiogenomics in unravelling incidental glioma grading and genetic status: where are we?","volume":"61","author":"Guarnera","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.mex.2026.103984_bib0035","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1007\/s00330-025-11898-2","article-title":"Diagnostic performance of deep learning for predicting glioma isocitrate dehydrogenase and 1p\/19q co-deletion in MRI: a systematic review and meta-analysis","volume":"36","author":"Farahani","year":"2025","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.mex.2026.103984_bib0036","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41698-024-00789-2","article-title":"A review of deep learning for brain tumor analysis in MRI","volume":"9","author":"Dorfner","year":"2025","journal-title":"NPJ. Precis. Oncol."},{"issue":"3","key":"10.1016\/j.mex.2026.103984_bib0037","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10278-024-01283-8","article-title":"Deep learning approaches for brain tumor detection and classification using MRI images (2020 to 2024): a systematic review","volume":"38","author":"Bouhafra","year":"2025","journal-title":"J Imaging Inform Med"},{"key":"10.1016\/j.mex.2026.103984_bib0038","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00234-025-03631-z","article-title":"MRI-derived deep learning models for predicting 1p\/19q codeletion status in glioma patients: a systematic review and meta-analysis of diagnostic test accuracy studies","volume":"67","author":"Ahmadzadeh","year":"2025","journal-title":"Neuroradiology."},{"key":"10.1016\/j.mex.2026.103984_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.crad.2025.107049","article-title":"Magnetic resonance imaging (MRI)-derived radiomics and deep learning models for predicting epidermal growth factor receptor status in glioma: a systematic review and meta-analysis","volume":"90","author":"Ahmadzadeh","year":"2025","journal-title":"Clin. Radiol."},{"issue":"1","key":"10.1016\/j.mex.2026.103984_bib0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40644-024-00682-y","article-title":"Artificial intelligence-based MRI radiomics and radiogenomics in glioma","volume":"24","author":"Fan","year":"2024","journal-title":"Cancer ImAging"},{"issue":"7","key":"10.1016\/j.mex.2026.103984_bib0041","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.mex.2026.103984_bib0042","doi-asserted-by":"crossref","first-page":"520","DOI":"10.11124\/JBIES-22-00123","article-title":"Recommendations for the extraction, analysis, and presentation of results in scoping reviews","volume":"21","author":"Pollock","year":"2023","journal-title":"JBI. Evid. Synth."},{"issue":"4","key":"10.1016\/j.mex.2026.103984_bib0043","doi-asserted-by":"crossref","first-page":"953","DOI":"10.11124\/JBIES-21-00242","article-title":"Best practice guidance and reporting items for the development of scoping review protocols","volume":"20","author":"Peters","year":"2022","journal-title":"JBI. Evid. Synth."},{"issue":"10","key":"10.1016\/j.mex.2026.103984_bib0044","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI. Evid. Synth."},{"key":"10.1016\/j.mex.2026.103984_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1200815","article-title":"Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors","volume":"13","author":"Guo","year":"2023","journal-title":"Front. Oncol."},{"issue":"26","key":"10.1016\/j.mex.2026.103984_bib0046","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","author":"Brat","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.mex.2026.103984_bib0047","article-title":"Incidence and survival of IDH-wildtype glioblastoma and IDH-mutant astrocytoma by treatment and sex: a regional study in Spain (2011-2021)","volume":"13","author":"Encarnacion","year":"2025","journal-title":"Med. Sci. (Basel)"},{"issue":"1","key":"10.1016\/j.mex.2026.103984_bib0048","first-page":"36","article-title":"The development of software to support multiple systematic review types: the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI)","volume":"17","author":"Munn","year":"2019","journal-title":"JBI. Evid. Implement."}],"container-title":["MethodsX"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215016126002025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215016126002025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:49:29Z","timestamp":1791560969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2215016126002025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":48,"alternative-id":["S2215016126002025"],"URL":"https:\/\/doi.org\/10.1016\/j.mex.2026.103984","relation":{},"ISSN":["2215-0161"],"issn-type":[{"value":"2215-0161","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the role of advanced MRI in understanding glioblastoma biology: A scoping review protocol","name":"articletitle","label":"Article Title"},{"value":"MethodsX","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mex.2026.103984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103984"}}